David Giljohann

David Giljohann is an accomplished professional known for his leadership roles in prominent organizations within the biotechnology and pharmaceutical industry.

He holds a Doctor of Philosophy (Ph.D.) from Northwestern University, indicating his strong educational background.

David Giljohann has a wealth of experience, having served as the Chief Executive Officer at EVOQ Therapeutics, CEO at Exicure, Inc., and COO at Exicure.

He also played a vital role as the Co-Founder of Exicure Inc., demonstrating his entrepreneurial spirit and innovative mindset.

Prior to his executive roles, David Giljohann served as the Principal Scientist at AuraSense, LLC, showcasing his expertise in scientific research and development.

His journey in the industry began during his time as a student at Northwestern University, where he laid the foundation for his successful career.